SteQeyma™ 45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeymatm, a ...

A German multicentre study reveals strong patient demand for systemic therapy in atopic dermatitis and psoriasis. Learn more about treatment preferences and drivers.

In this MedPage Today video segment, Linda Stein Gold, MD, director of dermatology clinical research at the Henry Ford Health ...

The future of dermatology is no longer just skin deep. This year’s American Academy of Dermatology (AAD) annual meeting was held March 7-11, 2025, in Orlando, FL, and it showcased the specialty’s ...

PeptiDream is advancing the oral IL-17a/ IL-17F dual inhibitor peptide program into IND-enabling studies, while exploring ...

People taking methotrexate for a variety of conditions have been warned by the NHS that a number of symptoms and side effects ...

Winter is the best season to refresh your skin. Learn why cold weather and softer sunlight make treatments safer and more ...

Vanda Pharmaceuticals Inc. (Vanda) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for imsidolimab, a novel IgG4 IL-36 receptor ...

This retrospective analysis is published in Naunyn-Schmiedeberg's Archives of Pharmacology.

Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate into a phase 3 trial for severe alopecia ...

Drinking alcohol can cause both short- and long-term changes to your skin, including redness, flushing, and puffiness, as well as possibly exacerbating skin conditions like eczema, acne, and psoriasis ...